Publication | Closed Access

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy

MedicineImmunologyPathologyCancer DiagnosisPhase Ii StudyRecurrent Nasopharyngeal CarcinomaOncologyRadiation OncologyCancer ResearchCancer-associated Virus